158 related articles for article (PubMed ID: 36729381)
1. Microsecretory Adenocarcinoma of Salivary Glands.
Bishop JA; Sajed DP
Adv Anat Pathol; 2023 Mar; 30(2):130-135. PubMed ID: 36729381
[TBL] [Abstract][Full Text] [Related]
2. Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.
Bishop JA; Weinreb I; Swanson D; Westra WH; Qureshi HS; Sciubba J; MacMillan C; Rooper LM; Dickson BC
Am J Surg Pathol; 2019 Aug; 43(8):1023-1032. PubMed ID: 31094920
[TBL] [Abstract][Full Text] [Related]
3. Microsecretory Adenocarcinoma of Salivary Glands: An Expanded Series of 24 Cases.
Bishop JA; Sajed DP; Weinreb I; Dickson BC; Bilodeau EA; Agaimy A; Franchi A; Khurram SA; Da Forno P; Robledo J; Kalmar JR; Aguirre S; Krane JF; Tapia JL; Kiss K; Cordell K; Rosebush M; Barrett AW; Oda D; Assaad A; Nagao T; Kawakami F; Nakaguro M; Zahir I; Wakeman K; Ihrler S; Chenevert J; Lin YL; Westra WH; Gagan J; Rooper LM
Head Neck Pathol; 2021 Dec; 15(4):1192-1201. PubMed ID: 33982215
[TBL] [Abstract][Full Text] [Related]
4. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
[TBL] [Abstract][Full Text] [Related]
5. Microsecretory adenocarcinoma of the skin harboring recurrent SS18 fusions: A cutaneous analog to a newly described salivary gland tumor.
Bishop JA; Williams EA; McLean AC; Gagan J; Rooper LM; Jordan RCK; LeBoit PE
J Cutan Pathol; 2023 Feb; 50(2):134-139. PubMed ID: 35690998
[TBL] [Abstract][Full Text] [Related]
6. Microsecretory adenocarcinoma: Cutaneous counterpart of a newly described salivary gland tumor with recurrent MEF2C::SS18 fusion.
Panse G
J Cutan Pathol; 2023 Feb; 50(2):188-190. PubMed ID: 36308392
[TBL] [Abstract][Full Text] [Related]
7. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
Skálová A; Hyrcza MD; Leivo I
Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
[TBL] [Abstract][Full Text] [Related]
8. Microsecretory Adenocarcinoma of the Ear Canal: Novel Cutaneous Analog of a Salivary Gland Neoplasm.
Chan MP; Flack AB; Grisel JJ; Harms PW; McHugh JB
Am J Dermatopathol; 2022 Nov; 44(11):855-858. PubMed ID: 35925564
[TBL] [Abstract][Full Text] [Related]
9. Microcribriform Adenocarcinoma of Salivary Glands: A Unique Tumor Entity Characterized by an SS18::ZBTB7A Fusion.
Weinreb I; Hahn E; Dickson BC; Rooper LM; Rupp NJ; Freiberger SN; Lubin D; Gagan J; Bishop JA
Am J Surg Pathol; 2023 Feb; 47(2):194-201. PubMed ID: 36221318
[TBL] [Abstract][Full Text] [Related]
10. Microsecretory adenocarcinoma of the external ear canal.
Dibbern ME; Gru AA; Stelow EB
J Cutan Pathol; 2023 Feb; 50(2):106-109. PubMed ID: 35710690
[TBL] [Abstract][Full Text] [Related]
11. Microsecretory adenocarcinoma of the hard palate: A case report of a recently described entity.
Kawakami F; Nagao T; Honda Y; Sakata J; Yoshida R; Nakayama H; Inoue S; Kitajima M; Ikeda O; Nakaguro M; Mikami Y
Pathol Int; 2020 Oct; 70(10):781-785. PubMed ID: 32687666
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Salivary Gland Tumors.
Seethala RR; Griffith CC
Surg Pathol Clin; 2016 Sep; 9(3):339-52. PubMed ID: 27523965
[TBL] [Abstract][Full Text] [Related]
13. New entity of microsecretory adenocarcinoma of salivary glands: first case with recurrence and metastases - proof of malignancy.
Jurmeister P; Haas C; Eisterer W; Rogatsch H; Ihrler S
Virchows Arch; 2022 Dec; 481(6):963-965. PubMed ID: 35780228
[TBL] [Abstract][Full Text] [Related]
14. Basal cell adenocarcinoma of minor salivary and seromucous glands of the head and neck region.
Fonseca I; Soares J
Semin Diagn Pathol; 1996 May; 13(2):128-37. PubMed ID: 8734419
[TBL] [Abstract][Full Text] [Related]
15. Emerging Entities in Salivary Pathology: A Practical Review of Sclerosing Microcystic Adenocarcinoma, Microsecretory Adenocarcinoma, and Secretory Myoepithelial Carcinoma.
Rooper LM
Surg Pathol Clin; 2021 Mar; 14(1):137-150. PubMed ID: 33526218
[TBL] [Abstract][Full Text] [Related]
16. Newly described salivary gland tumors.
Skalova A; Michal M; Simpson RH
Mod Pathol; 2017 Jan; 30(s1):S27-S43. PubMed ID: 28060365
[TBL] [Abstract][Full Text] [Related]
17. Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study.
Xu B; Barbieri AL; Bishop JA; Chiosea SI; Dogan S; Di Palma S; Faquin WC; Ghossein R; Hyrcza M; Jo VY; Lewis JS; Lozada JR; Michal M; Pareja FG; Perez-Ordonez B; Prasad ML; Purgina B; Reis-Filho JS; Scognamiglio T; Sebastiao APM; Seethala RR; Skálová A; Smith SM; Tekkeşin MS; Thompson LDR; Wasseman JK; Wenig BM; Weinreb I; Katabi N
Am J Surg Pathol; 2020 Apr; 44(4):545-552. PubMed ID: 31917707
[TBL] [Abstract][Full Text] [Related]
18. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.
Freiberger SN; Brada M; Fritz C; Höller S; Vogetseder A; Horcic M; Bihl M; Michal M; Lanzer M; Wartenberg M; Borner U; Bode PK; Broglie MA; Rordorf T; Morand GB; Rupp NJ
Neoplasia; 2021 May; 23(5):473-487. PubMed ID: 33878706
[TBL] [Abstract][Full Text] [Related]
19. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
[TBL] [Abstract][Full Text] [Related]
20. The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity: Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria.
Rooper LM; Mansour M; Yonescu R; Oliai BR; Bishop JA; Westra WH
Am J Surg Pathol; 2021 Jun; 45(6):753-764. PubMed ID: 33284193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
